Browse the world's most comprehensive database of hedge fund investor letters, sorted by recent quarter. Access primary source research from leading institutional managers.
Buyside Digest is not affiliated with, and does not endorse, Oakmark Select Fund. This analysis is provided for institutional research purposes only and is not investment advice.
Fund Returns
QTD+9.39%
YTD+0.65%
Annualized+12.08%
Positioning StanceNEUTRAL
Market CapLarge Cap
GeographyUS
Digest Analysis
Quick Take
"Oakmark Select underperformed in Q2 2026 as narrow AI-driven market leadership persisted, but the fund maintained its value discipline. Managed care holdings like Centene drove outperformance on stabilizing medical costs and improving reimbursement trends."
Executive Summary
The Oakmark Select Fund underperformed the S&P 500 Index during Q2 2026, returning 9.39% versus the benchmark's 15.20%, as the market's narrow leadership favoring AI beneficiaries persisted. The fund's value-oriented approach led it to avoid chasing popular themes, instead focusing on businesses trading at meaningful discounts to intrinsic value. Health care and consumer staples were the largest contributors to performance, while information technology and energy detracted. Centene was the top contributor, rallying sharply on better-than-expected results as medical cost trends show signs of stabilizing after two years of pressure. The managers expect easing medical costs combined with improving reimbursement rates to drive meaningful earnings recovery in managed care. Intercontinental Exchange was the top detractor due to market concerns about AI disruption, which the fund views as unfounded given the company's strong network effects and double-digit earnings growth. The fund made no new purchases during the quarter and exited positions in Deere and Warner Bros Discovery, maintaining its disciplined, concentrated approach.
Unlock Full Institutional Analysis
Sign in or create a free account to unlock full commentary, extracted equity pitches, and direct outbound manager source links with your 3 quarterly credits.
Algorithmic conviction, macroeconomic posture, and risk appetite signals extracted from this quarterly letter with qualitative explanations.
Signal Matrix
Market Conviction
72%
CautiousHigh
High Conviction (72%)
The fund runs a concentrated portfolio (Oakmark Select is known for 15-20 holdings) with specific position sizing disclosed: Centene 5.8%, Keurig Dr Pepper 7.6%, Salesforce 6.4%, ICON 4.9%, and Intercontinental Exchange 4.9%. The managers provide detailed, company-specific thesis commentary for top holdings with clear catalysts and timeframes ('meaningful earnings recovery in the coming years'). They demonstrate willingness to hold through volatility, explicitly dismissing market concerns about AI disruption to ICE. The absence of new purchases despite underperformance shows discipline rather than low conviction. However, the letter lacks the extreme concentration or 'largest position' language that would warrant 0.85+. This is high conviction within a concentrated value framework.
Growth Outlook
15%
BearishBullish
Bearish (15%)
The fund acknowledges the market's narrow leadership favoring AI beneficiaries but does not express enthusiasm for this dynamic. The letter describes a challenging environment for value strategies with no explicit bullish or bearish market view. The managers note opportunities in specific out-of-favor sectors like managed care but do not make broad market statements. The tone is neutral to mildly cautious about current market dynamics, warranting a score slightly above neutral.
Risk Appetite
25%
DefensiveAggressive
Defensive (25%)
The fund maintained existing positions with no new purchases during the quarter and exited two holdings (Deere and Warner Bros Discovery). This suggests a selective, disciplined posture rather than aggressive deployment. The managers are holding concentrated positions in out-of-favor areas like managed care while avoiding popular AI themes, indicating moderate conviction in current holdings but not maximum risk-on positioning. The stance is mildly positive but measured.
Capital Deployment
43%
De-riskingDeploying
Net Neutral (43%)
The fund made no new purchases during the quarter and completed final sales of two positions (Deere and Warner Bros Discovery). While specific cash levels are not disclosed, the absence of new deployment combined with position exits suggests a modest net reduction in exposure or at minimum a neutral stance. The managers are not aggressively putting capital to work despite seeing opportunities in specific holdings. This indicates slight de-risking or capital preservation, warranting a mildly negative score.
Forward Guidance
40%
CautiousExpansionary
Neutral (40%)
The fund expresses clear optimism about specific holdings and sectors, particularly managed care where they 'expect easing medical costs combined with improving reimbursement rates and Centene's own expense initiatives to drive a meaningful earnings recovery in the coming years.' They also state ICE 'is a durable business with a long runway for growth.' However, the absence of new purchases and the disciplined stance on avoiding popular themes suggests selective rather than broad-based deployment intent. The forward view is constructive on existing positions but not aggressively expansionary.
Language Signal
30%
BearishBullish
Bearish (30%)
The letter contains balanced directional language. Bullish terms include 'meaningful earnings recovery,' 'well positioned for growth,' 'long runway for growth,' 'attractive,' and 'durable business.' Bearish or cautious language includes 'underperformed,' 'under pressure,' 'concerns,' 'detractors,' and 'chasing the market's most popular themes' (used negatively). The net balance leans mildly positive as the managers express confidence in specific holdings and recovery themes, but the overall tone is measured and disciplined rather than enthusiastic.
Perceived Risk
35%
Low RiskElevated
Moderate Risk (35%)
The fund acknowledges specific risks in measured terms: managed care profitability 'has been under pressure over the last 2 years' and 'market concerns about AI disruption' affecting holdings. However, these risks are immediately contextualized with mitigating factors—medical cost trends are 'now stabilizing' and AI disruption concerns are dismissed as 'not credible threats.' The letter mentions 'narrow market leadership' as a headwind but does not frame this as a systemic risk. Risk discussion is present but not central to the narrative, and the managers express confidence in their ability to navigate these challenges. This warrants a moderate risk perception score.
Opportunity Density
45%
ScarceAbundant
Selective (45%)
The fund sees selective opportunities in specific areas like managed care where they expect 'meaningful earnings recovery' and view holdings like ICE as having 'a long runway for growth.' However, the absence of any new purchases during the quarter and the explicit statement that they are 'focused on owning businesses that trade at meaningful discounts to intrinsic value rather than chasing the market's most popular themes' suggests a more limited opportunity set. The managers are finding value in existing holdings but not discovering abundant new ideas, indicating moderate but not rich opportunity density.
Time Horizon
68%
Short-TermLong-Term
Multi-Year (68%)
The fund demonstrates a multi-year investment horizon with language like 'meaningful earnings recovery in the coming years' for managed care and 'long runway for growth' for Intercontinental Exchange. The managers are willing to hold through short-term underperformance and market concerns, as evidenced by maintaining ICE despite stock price declines and dismissing near-term AI disruption fears. However, the letter also discusses quarterly performance and near-term catalysts like 'first-quarter results' and 'stabilizing' cost trends, indicating some attention to 1-3 year timeframes rather than purely decade-plus horizons. This is a clear multi-year but not permanent capital timeframe.